Quote:

---

We will achieve that with a phase 3 long hauler study. We have had discussions with the FDA and have incorporated their advice into the trial protocol, which has been written and is ready to be filed.

---

Quote:

---

Since when has the FDA been talking to individual shareholders?

---

They may be trying to pull a fast one on the FDA by using a claim by Patterson of doing an independent study. Except he has no access to leronlimab so no study could be filed now. A study could be filed if they were able to gain control at the shareholders meeting and a longhaulers trial could start well after that. Why would they think delaying the start of the longhaulers trial by months would be viewed as beneficial?

Anyone feel free to post that at Reddit in response to that nonsense.